Zengfei X. Xia

State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

A Machine Learning Model to Predict Post-Operative Intensive Care Unit Admission in Patients with Cancer Based on Clinical Characteristics and Hematologic Parameters Data.

A Machine Learning Model to Predict Post-Operative Intensive Care Unit Admission in Patients with Cancer Based on Clinical Characteristics and Hematologic Parameters Data.

Journal: Journal of clinical medicine

Published: February 26, 2026

A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK-β.

A20 Facilitates Oxaliplatin Sensitivity in Colorectal Cancer Through Monoubiquitylation of IKK-β.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 31, 2025

Olverembatinib, a novel BCR-ABL tyrosine kinase inhibitor, exhibits anti-tumor activity and synergizes with gemcitabine in pancreatic ductal adenocarcinoma.

Olverembatinib, a novel BCR-ABL tyrosine kinase inhibitor, exhibits anti-tumor activity and synergizes with gemcitabine in pancreatic ductal adenocarcinoma.

Journal: NPJ precision oncology

Published: July 17, 2025

Fibroblast-derived PI16 enhances tumor immune-suppressive microenvironment via inducing Tregs differentiation.

Fibroblast-derived PI16 enhances tumor immune-suppressive microenvironment via inducing Tregs differentiation.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: April 09, 2025

CCL5hi Macrophages Interact with CD8+ T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma.

CCL5hi Macrophages Interact with CD8+ T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 05, 2024

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.

The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.

Journal: Cellular & molecular immunology

Published: March 17, 2023

A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1.

A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1.

Journal: Genes

Published: February 14, 2023

Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.

Prognostic significance of CDC25C in lung adenocarcinoma: An analysis of TCGA data.

Journal: Cancer genetics

Published: January 04, 2019

The efficacy and safety of ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: A network meta-analysis.

The efficacy and safety of ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: A network meta-analysis.

Journal: Cancer medicine

Published: May 18, 2018

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis.

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis.

Journal: OncoTargets and therapy

Published: March 15, 2018

Time-dependent Protein Expressions of MMP-2 and MMP-9 in Liver Contusion Rats after Impact

Time-dependent Protein Expressions of MMP-2 and MMP-9 in Liver Contusion Rats after Impact

Journal: Fa yi xue za zhi

Published: November 25, 2016

CARMA3 regulates the invasion, migration, and apoptosis of non-small cell lung cancer cells by activating NF-кB and suppressing the P38 MAPK signaling pathway.

CARMA3 regulates the invasion, migration, and apoptosis of non-small cell lung cancer cells by activating NF-кB and suppressing the P38 MAPK signaling pathway.

Journal: Experimental and molecular pathology

Published: June 07, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026